Your browser doesn't support javascript.
loading
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial.
Raphael Daniela, D B; Russell, N S; van Werkhoven, E; Immink, J M; Westhoff, D P G; Stenfert Kroese, M C; Stam, M R; van Maurik, L M; van Gestel, C M J; van der Weijden, T; Boersma, L J.
Afiliação
  • Raphael Daniela DB; Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229 ET, Maastricht, The Netherlands.
  • Russell NS; Department of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.
  • van Werkhoven E; Department of Radiotherapy, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Immink JM; Department of Radiotherapy, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Westhoff DPG; Department of Biometrics, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Stenfert Kroese MC; Department of Radiation Oncology, Reinier de Graaf Hospital, Delft, The Netherlands.
  • Stam MR; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Maurik LM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Gestel CMJ; Radiotherapy Group, Deventer, The Netherlands.
  • van der Weijden T; Radiotherapy Group, Arnhem, The Netherlands.
  • Boersma LJ; Department of Radiation Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Breast Cancer Res Treat ; 185(3): 685-695, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33099691
ABSTRACT

PURPOSE:

Patient decision aids (PtDAs) have been reported to have a positive influence on patients making a health care decision in trials. Nevertheless, post-trial implementation is poor. The aim of this study is to explore patient, clinician, and organizational success factors for implementing a PtDA designed for breast cancer patients, facing a decision on their radiation treatment.

METHODS:

We performed a process evaluation within a multi-center pre- and post-implementation trial. The PtDA was incorporated as much as possible in the logistics of 13 participating centers. Tracking data were collected on PtDA use. Process characteristics were recorded by both clinicians and patients. A logistic regression method was applied to investigate which process characteristics were significantly related to the probability that patients logged in to the PtDA.

RESULTS:

189 patients received the PtDA of whom140 (77%) used the PtDA. If patients received the link via the surgery department they were more likely to use the PtDA (OR 9.77 (1.28-74.51)), compared to patients that received the link via the radiation oncology department. If the report of the multidisciplinary team stated that radiation treatment "had to be discussed with the patient", patients were more likely to use the PtDA (OR 2.29 (1.12-4.71)). Educational level was not related to the probability of PtDA use.

CONCLUSIONS:

We accomplished a high level of PtDA use. Patients were more likely to use the PtDA if they received the link via the surgery department and if "to be discussed with the patient" was written in the multidisciplinary team report.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Técnicas de Apoio para a Decisão Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Técnicas de Apoio para a Decisão Idioma: En Ano de publicação: 2021 Tipo de documento: Article